US EditionDaewoong Microneedle Patch Hits Best-in-Class Bioavailability
Summary by AI TechPark
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Daewoong Microneedle Patch Hits Best-in-Class Bioavailability
More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmark A potential game changer that addresses both the pain of injections and the low efficiency of oral formulations In the obesity treatment market, delivery technology is expected to be the decisive factor shaping future leaders Daewoong Pharmaceutical (Co-CEOs Seong…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
